Market closed

CVRx/$CVRX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About CVRx

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

Ticker

$CVRX
Trading on

Industry

Health Care Equipment & Supplies

Employees

200

CVRx Metrics

BasicAdvanced
$330M
Market cap
-
P/E ratio
-$2.71
EPS
1.11
Beta
-
Dividend rate
$330M
1.11
$33.14
$6.40
316K
11.316
9.975
76.96
77.382
-17.04%
-31.44%
-79.02%
6.227
5.05
5.05
-7.274
34.38%
31.57%
60.33%
-26.23%

What the Analysts think about CVRx

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for CVRx stock.

CVRx Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

CVRx Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CVRX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for CVRx stock?

CVRx (CVRX) has a market cap of $330M as of December 13, 2024.

What is the P/E ratio for CVRx stock?

The price to earnings (P/E) ratio for CVRx (CVRX) stock is 0 as of December 13, 2024.

Does CVRx stock pay dividends?

No, CVRx (CVRX) stock does not pay dividends to its shareholders as of December 13, 2024.

When is the next CVRx dividend payment date?

CVRx (CVRX) stock does not pay dividends to its shareholders.

What is the beta indicator for CVRx?

CVRx (CVRX) has a beta rating of 1.11. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.